http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 25 Sep 2026 17:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Change+of+Chief+Executive+Officer/27108082.html <p align="justify">EDMONTON, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today announces the change of its Chief Executive Officer (CEO). Effective November 23, 2026, Dr. Madi Madiyalakan will be retiring from his position as Quest’s CEO. Dr. Madiyalakan has been the CEO of Quest since August 2006. Mr. Jeffrey Shon, a director of Quest, will be taking over the role of CEO. Mr. Shon has considerable experience in the areas of http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Change+of+Chief+Executive+Officer/27108082.html Fri, 25 Sep 2026 17:00:00 -0400 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Change+of+Chief+Executive+Officer/27108082.html <p align="justify">EDMONTON, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today announces the change of its Chief Executive Officer (CEO). Effective November 23, 2026, Dr. Madi Madiyalakan will be retiring from his position as Quest’s CEO. Dr. Madiyalakan has been the CEO of Quest since August 2006. Mr. Jeffrey Shon, a director of Quest, will be taking over the role of CEO. Mr. Shon has considerable experience in the areas of http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Change+of+Chief+Executive+Officer/27108082.html Fri, 25 Sep 2026 17:00:00 -0400 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Provides+Corporate+Update+including+Voluntary+Adoption+of+CSA+Blanket+Order+51-93+to+File+Financial+Statements+and+MD%26amp%3BA+on+Semi-Annual+Basis/26576246.html <p align="justify">EDMONTON, Alberta, May 29, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today provided a corporate update and announced that it has filed its annual audited financial statements for the year ended January 31, 2026, Management’s Discussion and Analysis and related filings on SEDAR+ (<a target="_blank" href="http://www.sedarplus.ca">www.sedarplus.ca</a>). The Company reported net income of $5.0 million, total liabilities of $1.3 million and total assets of $27.8 million, including a 26.6% equity interest in a http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Provides+Corporate+Update+including+Voluntary+Adoption+of+CSA+Blanket+Order+51-93+to+File+Financial+Statements+and+MD%26amp%3BA+on+Semi-Annual+Basis/26576246.html Fri, 29 May 2026 17:00:00 -0400 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Provides+Corporate+Update+including+Voluntary+Adoption+of+CSA+Blanket+Order+51-93+to+File+Financial+Statements+and+MD%26amp%3BA+on+Semi-Annual+Basis/26576246.html <p align="justify">EDMONTON, Alberta, May 29, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today provided a corporate update and announced that it has filed its annual audited financial statements for the year ended January 31, 2026, Management’s Discussion and Analysis and related filings on SEDAR+ (<a target="_blank" href="http://www.sedarplus.ca">www.sedarplus.ca</a>). The Company reported net income of $5.0 million, total liabilities of $1.3 million and total assets of $27.8 million, including a 26.6% equity interest in a http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Provides+Corporate+Update+including+Voluntary+Adoption+of+CSA+Blanket+Order+51-93+to+File+Financial+Statements+and+MD%26amp%3BA+on+Semi-Annual+Basis/26576246.html Fri, 29 May 2026 17:00:00 -0400 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Provides+Corporate+Update+including+Voluntary+Adoption+of+CSA+Blanket+Order+51-93+to+File+Financial+Statements+and+MD%26amp%3BA+on+Semi-Annual+Basis/26576246.html <p align="justify">EDMONTON, Alberta, May 29, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today provided a corporate update and announced that it has filed its annual audited financial statements for the year ended January 31, 2026, Management’s Discussion and Analysis and related filings on SEDAR+ (<a target="_blank" href="http://www.sedarplus.ca">www.sedarplus.ca</a>). The Company reported net income of $5.0 million, total liabilities of $1.3 million and total assets of $27.8 million, including a 26.6% equity interest in a http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Provides+Corporate+Update+including+Voluntary+Adoption+of+CSA+Blanket+Order+51-93+to+File+Financial+Statements+and+MD%26amp%3BA+on+Semi-Annual+Basis/26576246.html Fri, 29 May 2026 17:00:00 -0400 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Provides+Corporate+Update+including+Voluntary+Adoption+of+CSA+Blanket+Order+51-93+to+File+Financial+Statements+and+MD%26amp%3BA+on+Semi-Annual+Basis/26576246.html <p align="justify">EDMONTON, Alberta, May 29, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today provided a corporate update and announced that it has filed its annual audited financial statements for the year ended January 31, 2026, Management’s Discussion and Analysis and related filings on SEDAR+ (<a target="_blank" href="http://www.sedarplus.ca">www.sedarplus.ca</a>). The Company reported net income of $5.0 million, total liabilities of $1.3 million and total assets of $27.8 million, including a 26.6% equity interest in a http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Provides+Corporate+Update+including+Voluntary+Adoption+of+CSA+Blanket+Order+51-93+to+File+Financial+Statements+and+MD%26amp%3BA+on+Semi-Annual+Basis/26576246.html Fri, 29 May 2026 17:00:00 -0400 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html <p>EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders.</p> <p align="justify">The Company announces the following 4 directors have been re-elected to the Company’s Board of Directors:</p> <p align="justify">J. Mark Lievonen, C.M., FCPA, FCA, LLD <br/>Jeffrey Shon, J.D.<br/>Madi R. Madiyalakan, Ph.D.<br/>Bradley J. Glass, J.D.</p> <p align="justify">At the meeting, shareholders reappointed the Company’s auditors, Kingston Ross Pasnak, LLP.</p> <p align="justify">“I would like to thank all of our Board members for their service to the Company”, http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Results+from+AGM/25260934.html Wed, 27 Aug 2025 14:57:00 -0400 A.19134880 A.50208731 O.00416607 O.02555813 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html <p align="justify">EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that Quest was not informed or consulted, opposes and will not support the recently announced acquisition by privately held South Korea-based OQPBIOM Inc. (“OQM”) of a controlling interest in AdBioTech Co., Ltd. (“AdBioTech”), a public company listed on KOSDAQ in South Korea. OQM has announced that AdBioTech is the corporate vehicle through which it wishes to pursue the funding http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html Tue, 10 Jun 2025 19:14:00 -0400 A.50208731 O.02555813 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html <p align="justify">EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that Quest was not informed or consulted, opposes and will not support the recently announced acquisition by privately held South Korea-based OQPBIOM Inc. (“OQM”) of a controlling interest in AdBioTech Co., Ltd. (“AdBioTech”), a public company listed on KOSDAQ in South Korea. OQM has announced that AdBioTech is the corporate vehicle through which it wishes to pursue the funding http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html Tue, 10 Jun 2025 19:14:00 -0400 A.50208731 O.02555813 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html <p align="justify">EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that Quest was not informed or consulted, opposes and will not support the recently announced acquisition by privately held South Korea-based OQPBIOM Inc. (“OQM”) of a controlling interest in AdBioTech Co., Ltd. (“AdBioTech”), a public company listed on KOSDAQ in South Korea. OQM has announced that AdBioTech is the corporate vehicle through which it wishes to pursue the funding http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html Tue, 10 Jun 2025 19:14:00 -0400 A.50208731 O.02555813 O.02619036 QPT http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html <p align="justify">EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that Quest was not informed or consulted, opposes and will not support the recently announced acquisition by privately held South Korea-based OQPBIOM Inc. (“OQM”) of a controlling interest in AdBioTech Co., Ltd. (“AdBioTech”), a public company listed on KOSDAQ in South Korea. OQM has announced that AdBioTech is the corporate vehicle through which it wishes to pursue the funding http://www.streetinsider.com/Press+Releases/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html Tue, 10 Jun 2025 19:14:00 -0400 A.50208731 O.02555813 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html <p align="justify">EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that Quest was not informed or consulted, opposes and will not support the recently announced acquisition by privately held South Korea-based OQPBIOM Inc. (“OQM”) of a controlling interest in AdBioTech Co., Ltd. (“AdBioTech”), a public company listed on KOSDAQ in South Korea. OQM has announced that AdBioTech is the corporate vehicle through which it wishes to pursue the funding http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html Tue, 10 Jun 2025 19:14:00 -0400 A.50208731 O.02555813 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html <p align="justify">EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that Quest was not informed or consulted, opposes and will not support the recently announced acquisition by privately held South Korea-based OQPBIOM Inc. (“OQM”) of a controlling interest in AdBioTech Co., Ltd. (“AdBioTech”), a public company listed on KOSDAQ in South Korea. OQM has announced that AdBioTech is the corporate vehicle through which it wishes to pursue the funding http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html Tue, 10 Jun 2025 19:14:00 -0400 A.50208731 O.02555813 O.02619036 QPT http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html <p align="justify">EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that Quest was not informed or consulted, opposes and will not support the recently announced acquisition by privately held South Korea-based OQPBIOM Inc. (“OQM”) of a controlling interest in AdBioTech Co., Ltd. (“AdBioTech”), a public company listed on KOSDAQ in South Korea. OQM has announced that AdBioTech is the corporate vehicle through which it wishes to pursue the funding http://www.streetinsider.com/Globe+Newswire/Quest+PharmaTech+Announces+Opposition+to+OQPBIOM%26apos%3Bs+Acquisition+of+AdBioTech/24921839.html Tue, 10 Jun 2025 19:14:00 -0400 A.50208731 O.02555813 O.02619036 QPT